Sufrin Carolyn, Ziv Tali, Dayton Lauren, Latkin Carl, Kramer Camille
Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, 4940 Eastern Ave, Baltimore, MD, 21224, USA.
Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
SSM Qual Res Health. 2024 Dec;6. doi: 10.1016/j.ssmqr.2024.100453. Epub 2024 Jun 28.
Many pregnant individuals with opioid use disorder (OUD) spend time in jail, yet access to standard of care medications for OUD (MOUD) in jail is limited. Though qualitative studies of non-incarcerated pregnant and non-pregnant incarcerated individuals with OUD demonstrate complexities that must be considered in delivering effective care, studies with pregnant, incarcerated patients with OUD are lacking.
We conducted semi-structured qualitative interviews from October 2020-November 2021 with pregnant and postpartum people with OUD who were currently or previously in jail in Florida, Maryland, Ohio, and Virginia. Interview guides incorporated understandings of the power dynamics of incarceration and gendered expectations of motherhood. We analyzed transcripts using descriptive phenomenology to identify themes around experiences of treatment or withdrawal in jail and upon release.
We interviewed 32 women, 23 pregnant and nine postpartum. Some received MOUD in jail and others endured withdrawal. All participants expressed concern for their babies. Five themes emerged: 1)lack of counseling or accurate information about MOUD in pregnancy; 2)absent, delayed, or coercive care in jail; 3)experiences of stigma and discrimination from staff and caregivers; 4)structural barriers to safe transitions and continuing MOUD; and 5)the destructive presence of child protective services for care continuity. These factors all influenced their ability to recover.
Jails must provide OUD care that is attentive to pregnancy physiology, pregnancy-stigma, reentry needs, and patients' fetal-newborn concerns. Tailoring care specific to pregnancy and postpartum context can improve recovery success, reduce overdose, and promote intergenerational equity.
许多患有阿片类药物使用障碍(OUD)的孕妇会在监狱中度过一段时间,然而在监狱中获得针对OUD的标准护理药物(MOUD)的机会有限。尽管对未被监禁的患有OUD的孕妇和被监禁的非孕妇进行的定性研究表明,在提供有效护理时必须考虑到一些复杂性,但针对被监禁的患有OUD的孕妇的研究却很缺乏。
我们在2020年10月至2021年11月期间,对佛罗里达州、马里兰州、俄亥俄州和弗吉尼亚州目前或曾经入狱的患有OUD的孕妇和产后女性进行了半结构化定性访谈。访谈指南纳入了对监禁权力动态以及对母亲身份的性别期望的理解。我们使用描述性现象学分析访谈记录,以确定围绕在监狱中及出狱后的治疗或戒断经历的主题。
我们采访了32名女性,其中23名孕妇和9名产后女性。一些人在监狱中接受了MOUD,而另一些人则忍受了戒断反应。所有参与者都表达了对自己孩子的担忧。出现了五个主题:1)孕期缺乏关于MOUD的咨询或准确信息;2)监狱中的护理缺失、延迟或具有强制性;3)受到工作人员和护理人员的耻辱和歧视;4)安全过渡和持续使用MOUD的结构障碍;5)儿童保护服务对护理连续性的破坏性影响。这些因素都影响了她们的康复能力。
监狱必须提供关注妊娠生理、妊娠耻辱感、重新融入需求以及患者对胎儿 - 新生儿担忧的OUD护理。针对孕期和产后情况量身定制护理可以提高康复成功率、减少过量用药并促进代际公平。